Immune Thrombocytopenia Resolved by Eltrombopag in a Carrier of Glucose-6-Phosphate Dehydrogenase Deficiency
Main Authors: | Laura Scaramucci, Pasquale Niscola, Massimiliano Palombi, Andrea Tendas, Marco Giovannini, Paolo De Fabritiis |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2016-02-01
|
Series: | Turkish Journal of Hematology |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-27048 |
Similar Items
-
Eltrombopag Use in Children with Persistent and Chronic Primary Immune Thrombocytopenia in a Portuguese Pediatric Center
by: Caroline Lopes, et al.
Published: (2024-04-01) -
Advances in management of pediatric chronic immune thrombocytopenia: a narrative review
by: Jae Min Lee
Published: (2023-07-01) -
Safety, tolerance, pharmacokinetic and pharmacodynamic properties of thrombopoietin mimetic peptide for injection in Chinese healthy volunteers: a randomized, placebo-controlled, double-blind study
by: Xiao-Yan Sheng, et al.
Published: (2022-11-01) -
Clinical Presentation and Therapy of Primary Immune Thrombocytopenia Resistant to Splenectomy
by: Aleksandar Kara-Jovanović, et al.
Published: (2020-04-01) -
The role of thrombopoietin receptor agonists in the management of adult primary immune thrombocytopenia: A single centre experience
by: Virijević Marijana, et al.
Published: (2022-01-01)